These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 27589954)

  • 1. Deletion of interleukin-6 in monocytes/macrophages suppresses the initiation of hepatocellular carcinoma in mice.
    Kong L; Zhou Y; Bu H; Lv T; Shi Y; Yang J
    J Exp Clin Cancer Res; 2016 Sep; 35(1):131. PubMed ID: 27589954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.
    Ma HY; Yamamoto G; Xu J; Liu X; Karin D; Kim JY; Alexandrov LB; Koyama Y; Nishio T; Benner C; Heinz S; Rosenthal SB; Liang S; Sun M; Karin G; Zhao P; Brodt P; Mckillop IH; Quehenberger O; Dennis E; Saltiel A; Tsukamoto H; Gao B; Karin M; Brenner DA; Kisseleva T
    J Hepatol; 2020 May; 72(5):946-959. PubMed ID: 31899206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-23 production of liver inflammatory macrophages to damaged hepatocytes promotes hepatocellular carcinoma development after chronic hepatitis B virus infection.
    Zang M; Li Y; He H; Ding H; Chen K; Du J; Chen T; Wu Z; Liu H; Wang D; Cai J; Qu C
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3759-3770. PubMed ID: 30292634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient Kupffer cell depletion and subsequent replacement by infiltrating monocyte-derived cells does not alter the induction or progression of hepatocellular carcinoma.
    Vanderborght B; De Muynck K; Gijbels E; Lefere S; Scott CL; Guilliams M; Beschin A; Vinken M; Verhelst X; Geerts A; Van Vlierberghe H; Devisscher L
    Int J Cancer; 2023 Jun; 152(12):2615-2628. PubMed ID: 36912275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abberent expression of NOR1 protein in tumor associated macrophages contributes to the development of DEN-induced hepatocellular carcinoma.
    Chen S; Zheng P; Wang W; Yi M; Chen P; Cai J; Li J; Peng Q; Ban Y; Zhou Y; Zeng Z; Li X; Xiong W; Li G; Xiang B
    J Cell Physiol; 2018 Jun; 233(6):5002-5013. PubMed ID: 29227538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-15a/16-1 Prevents Hepatocellular Carcinoma by Disrupting the Communication Between Kupffer Cells and Regulatory T Cells.
    Liu N; Chang CW; Steer CJ; Wang XW; Song G
    Gastroenterology; 2022 Feb; 162(2):575-589. PubMed ID: 34678217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STK4 regulates TLR pathways and protects against chronic inflammation-related hepatocellular carcinoma.
    Li W; Xiao J; Zhou X; Xu M; Hu C; Xu X; Lu Y; Liu C; Xue S; Nie L; Zhang H; Li Z; Zhang Y; Ji F; Hui L; Tao W; Wei B; Wang H
    J Clin Invest; 2015 Nov; 125(11):4239-54. PubMed ID: 26457732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of relevant immune-modulators and cytokines in hepatocellular carcinoma and premalignant hepatic lesions.
    Zekri AN; El Deeb S; Bahnassy AA; Badr AM; Abdellateif MS; Esmat G; Salama H; Mohanad M; El-Dien AE; Rabah S; Abd Elkader A
    World J Gastroenterol; 2018 Mar; 24(11):1228-1238. PubMed ID: 29568203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-98 suppresses the effects of tumor-associated macrophages on promoting migration and invasion of hepatocellular carcinoma cells by regulating IL-10.
    Li L; Sun P; Zhang C; Li Z; Zhou W
    Biochimie; 2018 Jul; 150():23-30. PubMed ID: 29702181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B lymphocytes limit senescence-driven fibrosis resolution and favor hepatocarcinogenesis in mouse liver injury.
    Faggioli F; Palagano E; Di Tommaso L; Donadon M; Marrella V; Recordati C; Mantero S; Villa A; Vezzoni P; Cassani B
    Hepatology; 2018 May; 67(5):1970-1985. PubMed ID: 29105104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human interleukin 6 gene is activated by hepatitis B virus-X protein in human hepatoma cells.
    Lee Y; Park US; Choi I; Yoon SK; Park YM; Lee YI
    Clin Cancer Res; 1998 Jul; 4(7):1711-7. PubMed ID: 9676846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells.
    Kuang DM; Peng C; Zhao Q; Wu Y; Chen MS; Zheng L
    Hepatology; 2010 Jan; 51(1):154-64. PubMed ID: 19902483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C.
    Aroucha DC; do Carmo RF; Moura P; Silva JL; Vasconcelos LR; Cavalcanti MS; Muniz MT; Aroucha ML; Siqueira ER; Cahú GG; Pereira LM; Coêlho MR
    Cytokine; 2013 Jun; 62(3):421-5. PubMed ID: 23602201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-6 -174G/C polymorphism and IL-6 serum levels in patients with liver cirrhosis and hepatocellular carcinoma.
    Giannitrapani L; Soresi M; Giacalone A; Campagna ME; Marasà M; Cervello M; Marasà S; Montalto G
    OMICS; 2011 Mar; 15(3):183-6. PubMed ID: 21329460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis.
    Ogata H; Kobayashi T; Chinen T; Takaki H; Sanada T; Minoda Y; Koga K; Takaesu G; Maehara Y; Iida M; Yoshimura A
    Gastroenterology; 2006 Jul; 131(1):179-93. PubMed ID: 16831601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low serum interleukin-6 levels as a predictive marker of recurrence in patients with hepatitis B virus related hepatocellular carcinoma who underwent curative treatment.
    Cho HJ; Kim SS; Ahn SJ; Park SY; Park JH; Kim JK; Wang HJ; Cheong JY; Cho SW
    Cytokine; 2015 Jun; 73(2):245-52. PubMed ID: 25797190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte-specific HDAC3 ablation promotes hepatocellular carcinoma in females by suppressing Foxa1/2.
    Xu Y; Zhu Y; Wu Z; Li S; Shao M; Tao Q; Xu Q; Chen Y; Shu Y; Chen M; Zhou Y; Shi Y
    BMC Cancer; 2023 Sep; 23(1):906. PubMed ID: 37752418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6 and PD-L1 blockade combination inhibits hepatocellular carcinoma cancer development in mouse model.
    Liu H; Shen J; Lu K
    Biochem Biophys Res Commun; 2017 Apr; 486(2):239-244. PubMed ID: 28254435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional role of CCL5/RANTES for HCC progression during chronic liver disease.
    Mohs A; Kuttkat N; Reißing J; Zimmermann HW; Sonntag R; Proudfoot A; Youssef SA; de Bruin A; Cubero FJ; Trautwein C
    J Hepatol; 2017 Apr; 66(4):743-753. PubMed ID: 28011329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sympathetic nervous system promotes hepatocarcinogenesis by modulating inflammation through activation of alpha1-adrenergic receptors of Kupffer cells.
    Huan HB; Wen XD; Chen XJ; Wu L; Wu LL; Zhang L; Yang DP; Zhang X; Bie P; Qian C; Xia F
    Brain Behav Immun; 2017 Jan; 59():118-134. PubMed ID: 27585737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.